See more : Triterras, Inc. (TRIT) Income Statement Analysis – Financial Results
Complete financial analysis of Nuo Therapeutics, Inc. (AURX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nuo Therapeutics, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- BioPlus Acquisition Corp. (BIOSU) Income Statement Analysis – Financial Results
- West Mining Corp. (WESMF) Income Statement Analysis – Financial Results
- Broadscale Acquisition Corp. (SCLEU) Income Statement Analysis – Financial Results
- Shandong Nanshan Aluminium Co.,Ltd. (600219.SS) Income Statement Analysis – Financial Results
- Recruiter.com Group, Inc. (RCRT) Income Statement Analysis – Financial Results
Nuo Therapeutics, Inc. (AURX)
About Nuo Therapeutics, Inc.
Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing primarily in the United States. Its technology separates autologous blood to produce a platelet based therapy for the chronic wound care market. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was founded in 1998 and is based in Houston, Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 608.53K | 112.25K | 0.00 | 0.00 | 146.18K | 1.37M | 721.05K | 2.20M | 11.51M | 7.76M | 11.57M | 10.56M | 7.25M | 3.91M | 2.07M | 2.09M | 1.94M | 1.95M | 1.51M | 1.15M | 1.09M | 400.45K | 42.69K | 318.82K | 8.60K |
| Cost of Revenue | 126.09K | 19.21K | 0.00 | 0.00 | 114.61K | 162.99K | 1.09M | 1.99M | 7.97M | 6.77M | 8.45M | 3.91M | 2.73M | 1.61M | 458.81K | 601.02K | 850.29K | 1.01M | 881.32K | 711.83K | 758.43K | 62.05K | 0.00 | 61.95K | 25.87K |
| Gross Profit | 482.43K | 93.04K | 0.00 | 0.00 | 31.56K | 1.21M | -370.00K | 216.98K | 3.54M | 991.19K | 3.12M | 6.65M | 4.52M | 2.30M | 1.61M | 1.49M | 1.09M | 933.57K | 633.10K | 433.76K | 328.49K | 338.40K | 42.69K | 256.87K | -17.27K |
| Gross Profit Ratio | 79.28% | 82.88% | 0.00% | 0.00% | 21.59% | 88.11% | -51.31% | 9.84% | 30.79% | 12.77% | 26.95% | 62.95% | 62.37% | 58.76% | 77.79% | 71.25% | 56.24% | 47.92% | 41.80% | 37.86% | 30.22% | 84.51% | 100.00% | 80.57% | -200.81% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 181.19K | 576.19K | 1.33M | 1.46M | 2.55M | 2.62M | 3.80M | 3.39M | 98.15K | 415.63K | 227.49K | 145.71K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 90.67K | 378.06K | 789.12K | 2.02M | 3.82M | 5.10M | 9.02M | 17.07M | 17.41M | 16.16M | 7.94M | 7.29M | 4.83M | 5.69M | 4,567.57B | 2,549.89B | 2,491.40B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 30.46K | 114.88K | 712.74K | 1.73M | 6.24M | 5.78M | 0.00 | 7.11M | 0.00 | 0.00 | 0.00 | 0.00 | -4,567.56B | -2,549.88B | -2,491.39B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.65M | 3.41M | 90.67K | 378.06K | 819.58K | 2.14M | 4.54M | 7.13M | 15.26M | 17.07M | 17.41M | 16.16M | 7.94M | 7.29M | 4.83M | 5.69M | 6.45M | 5.09M | 8.08M | 8.62M | 4.46M | 2.00M | 1.75M | 1.79M | 244.97K |
| Other Expenses | 0.00 | 4.52K | 0.00 | 0.00 | -4.24K | 1.76K | 566.31K | 0.00 | -11.30K | -7.49K | 15.37K | -2.00M | 1,473.67B | 1,930.66B | 2,187.70B | 6,018.37B | 1,028.14B | 1,528.36B | 4,706.51B | 0.00 | 0.00 | 356.05K | 3.71M | 31.93M | 3.25M |
| Operating Expenses | 3.65M | 3.41M | 90.67K | 378.06K | 1.00M | 2.71M | 5.86M | 8.59M | 17.81M | 19.70M | 21.21M | 19.54M | 8.03M | 7.70M | 5.06M | 5.84M | 6.45M | 5.09M | 8.08M | 8.62M | 4.46M | 2.36M | 5.47M | 33.72M | 3.49M |
| Cost & Expenses | 3.78M | 3.43M | 90.67K | 378.06K | 1.12M | 2.88M | 6.96M | 10.58M | 25.78M | 26.47M | 29.67M | 23.46M | 10.76M | 9.31M | 5.52M | 6.44M | 7.30M | 6.11M | 8.96M | 9.33M | 5.22M | 2.42M | 5.47M | 33.79M | 3.52M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 28.34K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 296.88K | 244.60K | 101.56K | 54.24K | 7.77K | 6.50K | 28.51K | 199.60K | 0.00 | |
| Interest Expense | 3.16K | 2.10K | 48.39K | 221.46K | 38.89K | 10.82K | 0.00 | 3.80M | 3.43M | 1.68M | 1.04M | 1.05M | 798.67K | 9.76K | 156.61K | 0.00 | 0.00 | 0.00 | 192.00 | 950.00 | 22.83K | 5.64M | 16.36K | 0.00 | |
| Depreciation & Amortization | 105.26K | 74.08K | 90.67K | 89.86K | 89.86K | 102.20K | 1.11M | 1.23M | 740.97K | 613.50K | 1.09M | 1.18M | 631.18K | 440.18K | 33.41K | 170.77K | 157.93K | 197.19K | 2.21M | 3.32M | 1.19M | 137.59K | 458.61K | 115.67K | 4.06K |
| EBITDA | -3.06M | -3.10M | 0.00 | -288.20K | -879.34K | -1.40M | -13.85M | -6.75M | -48.36M | -14.82M | -17.46M | -17.56M | -1.81M | -5.56M | -3.21M | -7.49M | -4.88M | -3.96M | -6.28M | -4.87M | -2.94M | -1.88M | -4.04M | -33.35M | -3.50M |
| EBITDA Ratio | -503.35% | -2,888.19% | 0.00% | 0.00% | -665.93% | -102.20% | -710.24% | -323.99% | -117.24% | -241.11% | -143.01% | -55.58% | -39.78% | -111.52% | -165.39% | -34.13% | -268.27% | -288.16% | -401.56% | -424.86% | -270.49% | -401.87% | -37,622.25% | -10,336.99% | -9,663.03% |
| Operating Income | -3.17M | -3.32M | -90.67K | -378.06K | -969.20K | -1.50M | -15.53M | -8.37M | -41.32M | -23.39M | -18.10M | -12.89M | -3.51M | -5.40M | -3.45M | -7.89M | -5.35M | -4.16M | -7.45M | -8.19M | -4.13M | -2.02M | -5.42M | -33.47M | -6.19M |
| Operating Income Ratio | -520.65% | -2,958.21% | 0.00% | 0.00% | -663.03% | -109.78% | -2,154.40% | -379.74% | -358.96% | -301.35% | -156.38% | -122.06% | -48.49% | -138.15% | -166.95% | -377.57% | -275.46% | -213.50% | -491.68% | -714.77% | -380.13% | -504.05% | -12,702.65% | -10,497.45% | -71,948.35% |
| Total Other Income/Expenses | -3.16K | 148.86K | 0.00 | 287.19K | -225.70K | -37.12K | 555.50K | 30.85M | -11.58M | 4.53M | -2.13M | -6.89M | -42.20K | -1.46M | 190.25K | -3.31M | 315.13K | 1.90M | 942.65K | -5.02K | 6.82K | -271.60K | 5.42M | -395.91K | 6.19M |
| Income Before Tax | -3.17M | -3.17M | -90.67K | -90.87K | -1.19M | -1.54M | -14.98M | 22.48M | -52.90M | -18.86M | -20.23M | -19.78M | -3.49M | -6.80M | -3.44M | -7.66M | -5.04M | -2.26M | -6.50M | -8.14M | -4.12M | -2.02M | -21.23M | -33.26M | -6.19M |
| Income Before Tax Ratio | -521.17% | -2,825.60% | 0.00% | 0.00% | -817.43% | -112.49% | -2,077.36% | 1,019.58% | -459.54% | -243.03% | -174.83% | -187.24% | -48.19% | -173.94% | -166.42% | -366.41% | -259.25% | -116.16% | -429.44% | -710.49% | -379.50% | -503.67% | -49,729.27% | -10,430.75% | -71,976.94% |
| Income Tax Expense | 0.00 | -146.44K | 287.19B | 48.39K | 221.46K | 37.12K | -555.50K | 0.00 | -89.01K | 19.58K | 18.59K | 18.00K | 18.00K | 14.00K | -9.76K | -156.61K | -315.13K | -1.90M | 6.50M | 8.14M | 4.12M | 2.02M | 21.23M | 33.26M | 6.19M |
| Net Income | -3.17M | -3.03M | -90.67K | -139.26K | -1.42M | -1.54M | -14.98M | 22.48M | -52.81M | -18.88M | -20.25M | -19.80M | -3.51M | -6.82M | -3.44M | -7.66M | -5.04M | -2.26M | -6.50M | -8.14M | -4.12M | -2.02M | -21.23M | -33.26M | -6.19M |
| Net Income Ratio | -521.17% | -2,695.14% | 0.00% | 0.00% | -968.93% | -112.49% | -2,077.36% | 1,019.58% | -458.76% | -243.28% | -174.99% | -187.41% | -48.44% | -174.30% | -166.42% | -366.41% | -259.25% | -116.16% | -429.44% | -710.49% | -379.50% | -503.67% | -49,729.27% | -10,430.75% | -71,976.94% |
| EPS | -0.08 | -0.08 | 0.00 | -0.01 | -0.06 | -0.07 | -1.02 | 2.26 | -0.42 | -0.16 | -0.20 | -0.24 | -0.07 | -0.18 | -0.10 | -0.24 | -0.17 | -0.08 | -0.27 | -0.46 | -0.35 | -0.22 | -1.80 | -3.25 | -0.93 |
| EPS Diluted | -0.08 | -0.08 | 0.00 | -0.01 | -0.06 | -0.07 | -1.02 | 2.26 | -0.42 | -0.16 | -0.20 | -0.24 | -0.07 | -0.18 | -0.10 | -0.24 | -0.17 | -0.08 | -0.27 | -0.46 | -0.35 | -0.22 | -1.80 | -3.25 | -0.93 |
| Weighted Avg Shares Out | 42.08M | 40.00M | 30.30M | 25.69M | 23.72M | 23.28M | 14.65M | 9.93M | 125.95M | 120.52M | 103.62M | 81.86M | 50.67M | 38.67M | 35.12M | 32.52M | 29.82M | 27.47M | 24.43M | 17.87M | 11.84M | 9.17M | 11.76M | 10.24M | 6.64M |
| Weighted Avg Shares Out (Dil) | 42.08M | 40.00M | 30.30M | 27.31M | 23.72M | 23.28M | 14.65M | 9.93M | 125.95M | 120.52M | 103.62M | 81.86M | 50.67M | 38.67M | 35.12M | 32.52M | 29.82M | 27.47M | 24.43M | 17.87M | 11.84M | 9.17M | 11.76M | 10.24M | 6.64M |
No news found for: AURX
Source: https://incomestatements.info
Category: Stock Reports